UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014105
Receipt number R000016232
Scientific Title Registry focused on very early presentation and treatment in emergency department of acute heart failure syndrome
Date of disclosure of the study information 2014/05/30
Last modified on 2019/01/14 01:38:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Registry focused on very early presentation and treatment in emergency department of acute heart failure syndrome

Acronym

REALITY-AHF

Scientific Title

Registry focused on very early presentation and treatment in emergency department of acute heart failure syndrome

Scientific Title:Acronym

REALITY-AHF

Region

Japan


Condition

Condition

Acute Heart Failure Syndrome

Classification by specialty

Medicine in general Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the current state of super-acute phase treatment for acute heart failure syndrome (AHFS) including in emergency department (ED) and it's effect on prognosis .

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Combined endpoint of all cause mortality and readmission due to heart failure within 1 year.

Key secondary outcomes

In-hospital death; all cause mortality within 30 days/90 days/1 year after discharge; heart failure readmission rate within 30 days/90 days/1 year after discharge.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. AHFS patients who are admitted via emergency department.
2. The AHFS is diagnosed according to Framingham criteria.
3. Over 20 years old.
4. AHFS was diagnosed within 3 hours after arriving to ED and physical exam was taken by medical staff.

Key exclusion criteria

1. After cardiac transplantation
2. Chronic hemodialysis
3. Acute myocarditis
4. Acute coronary syndrome require emergent revascularization
5. BNP level < 100 pg/mL or N-terminal-proBNP level < 300 pg/mL at baseline

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuya Matsue

Organization

Kameda Medical Center

Division name

Department of Cardiology

Zip code


Address

929, Higashi-Cho, Kamogawa, Chiba

TEL

047-092-2211

Email

yuya8950@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takeshi Kitai

Organization

Kobe City Medical Center General Hospital

Division name

Department of Cardiology

Zip code


Address

2-2-1, Minatojimaminamimachi, Chuo-ku, Kobe-city, Hyogo, 650-0047, Japan

TEL

078-302-4321

Homepage URL


Email

t-kitai@kcho.jp


Sponsor or person

Institute

U-40 HF Network

Institute

Department

Personal name



Funding Source

Organization

The Cardiovascular Research Fund, Tokyo, Japan

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

亀田メディカルセンター(千葉)・神戸市立医療センター中央市民病院(兵庫)・聖路加国際病院(東京)・聖マリアンナ医科大学(神奈川)・北里大学(神奈川)・東京医科大学茨城医療センター(茨城)・東京医科歯科大学(東京)・福島県立医科大学(福島)・筑波大学(茨城)・横浜市立大学附属市民総合医療センター(神奈川)・日本医科大学(東京)・日本医科大学武蔵小杉病院(神奈川)・名古屋大学(愛知)・関西労災病院(大阪)・西宮渡辺心臓血管センター(大阪)・心臓病センター榊原病院(岡山)・兵庫県立姫路循環器病センター(兵庫)・神戸百年記念病院(兵庫)・武蔵野赤十字病院(東京)・済生会福岡総合病院(福岡)・高知大学(高知)・滋賀県立成人病センター(滋賀)・赤穂市民病院(兵庫)・豊見城中央病院(沖縄)


Other administrative information

Date of disclosure of the study information

2014 Year 05 Month 30 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2014 Year 06 Month 15 Day

Date of IRB


Anticipated trial start date

2014 Year 08 Month 01 Day

Last follow-up date

2017 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Elucidate the correlation between therapy for AHFS in acute phase and prognosis by prospective multicenter registry in Japan.


Management information

Registered date

2014 Year 05 Month 29 Day

Last modified on

2019 Year 01 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016232


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name